SARS-CoV-2 testing among patients and healthcare professionals in an HIV outpatient clinic in Brazil
Rev. Inst. Med. Trop. São Paulo (Online)
; 64: e3, 2022. tab
Article
in English
|
LILACS-Express
| LILACS
| ID: biblio-1360803
Responsible library:
BR1.1
ABSTRACT
ABSTRACT The COVID-19 pandemic in Brazil has been marked by high infection and death rates. The immune response generated by current vaccination might be influenced by previous natural infection, and baseline estimates may help in the evaluation of vaccine-induced serological response. We evaluated previous SARS-CoV-2 testing (RT-PCR), and performed rapid diagnostic tests (RDT) and high throughput electrochemiluminescence immunoassay (ECLIA) before vaccination among people living with HIV (PLWH), users of antiretroviral prophylaxis (PrEP/PEP), and healthcare professionals in an HIV outpatient clinic (HCP-HC). RDT was positive in 25.7% (95% CI 19-33%) overall, 31.3% (95% CI 18-45%) among PLWH, 23.7% (95% CI 14-34%) in PrEP/PEP users and 21.4% (95% CI 05-28%) in HCP-HC (p=0.548). Diagnostic RT-PCR testing was very limited, even for symptomatic individuals, and whereas all HCP-HC had one test perfomed, only 35% of the patients (PREP/PEP/PLWH) were tested (p<0.0001). Adequate monitoring of post-vaccination humoral response and breakthrough infections including those in asymptomatic cases are warranted, especially in immunologically compromised individuals.
Full text:
Available
Collection:
International databases
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 3 Human resources for health
Database:
LILACS
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Rev. Inst. Med. Trop. São Paulo (Online)
Journal subject:
Medicina Tropical
Year:
2022
Document type:
Article
/
Project document
Affiliation country:
Brazil
Institution/Affiliation country:
Instituto Adolfo Lutz/BR
/
Secretaria Municipal de Saúde/BR
/
Universidade do Estado de São Paulo/BR